Actively Recruiting
Cannabis Abstinence and Neurocognitive Assessment in Adolescence
Led by University Hospital Pilsen · Updated on 2025-09-19
29
Participants Needed
1
Research Sites
247 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Cannabis Abstinence and Neurocognitive Assessment in Adolescence
CONDITIONS
Official Title
Cannabis Abstinence and Neurocognitive Assessment in Adolescence
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adolescents aged 15-18 years with a diagnosis of cannabis dependence or harmful cannabis use.
You will not qualify if you...
- Psychiatric comorbidity including psychotic disorders, mood disorders, severe organic brain damage, or autism spectrum disorder, except for compensated and stabilized anxiety disorder.
- Psychopharmacological treatment is allowed except antipsychotics prescribed for psychosis.
- Severe somatic comorbidities such as diabetes mellitus, thyroid dysfunction, or severe cardiovascular disease.
- Violation of abstinence between the first and second neuropsychological assessments.
- Severe mental state decompensation requiring changes in psychopharmacological treatment.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Hospital Pilsen
Pilsen, Czechia, Czechia, 30100
Actively Recruiting
Research Team
J
Jiri Podlipny, MD, Ph.D.
CONTACT
F
Frantisek Nekvapil, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here